Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model

被引:4
|
作者
Zhang, Xueying [1 ]
He, Zijun [1 ]
Zhang, Yucong [2 ]
Kong, Jian [3 ]
机构
[1] Jinan Univ, Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
[2] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Clin Med Coll 2, Dept Radiat Oncol,Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China
[3] Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp,Affiliated Hosp 1, Dept Intervent Radiol,Clin Med Coll 2, Shenzhen, Guangdong, Peoples R China
关键词
hepatocellular carcinoma; drug-eluting beads transcatheter arterial chemoembolization; initial response; objective response; computed tomography; radiomics; nomogram; prediction; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-CANCER; TIME-POINT; DC BEAD; MRECIST; CLASSIFICATION; SURVIVAL; HETEROGENEITY; SYSTEM; EASL;
D O I
10.3389/fphar.2024.1315732
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: A prognostic model utilizing CT radiomics, radiological, and clinical features was developed and validated in this study to predict an objective response to initial transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma (HCC).Methods: Between January 2017 and December 2022, the baseline clinical characteristics and preoperative and postoperative follow-up imaging data of 108 HCC patients who underwent the first time treatment of DEB-TACE were analyzed retrospectively. The training group (n = 86) and the validation group (n = 22) were randomly assigned in an 8:2 ratio. By logistic regression in machine learning, radiomics, and clinical-radiological models were constructed separately. Finally, the integrated model construction involved the integration of both radiomics and clinical-radiological signatures. The study compared the integrated model with radiomics and clinical-radiological models using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA).Results: The objective response rate observed in a group of 108 HCC patients who received initial DEB-TACE treatment was found to be 51.9%. Among the three models, the integrated model exhibited superior predictive accuracy in both the training and validation groups. The training group resulted in an area under the curve (AUC) of 0.860, along with sensitivity and specificity values of 0.650 and 0.913, respectively. Based on the findings from the validation group, the AUC was estimated to be 0.927. Additionally, it was found that values of sensitivity and specificity were 0.875 and 0.833, respectively. In the validation group, the AUC of the integrated model showed a significant improvement when contrasted to the clinical-radiological model (p = 0.042). Nevertheless, no significant distinction was observed in the AUC when comparing the integrated model with the radiomics model (p = 0.734). The DCA suggested that the integrated model demonstrates advantageous clinical utility.Conclusion: The integrated model, which combines the CT radiomics signature and the clinical-radiological signature, exhibited higher predictive efficacy than either the radiomics or clinical-radiological models alone. This suggests that during the prediction of the objective responsiveness of HCC patients to the first DEB-TACE treatment, the integrated model yields superior outcomes.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective study
    Xue, Miao
    Wu, Yanqin
    Zhu, Bowen
    Zou, Xinhua
    Fan, Wenzhe
    Li, Jiaping
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6107 - 6118
  • [32] Machine Learning-Based Development of Nomogram for Hepatocellular Carcinoma to Predict Acute Liver Function Deterioration After Drug-Eluting Beads Transarterial Chemoembolization
    Li, Jie
    Zhang, Yuyuan
    Ye, Heqing
    Hu, Luqi
    Li, Xin
    Li, Yifan
    Yu, Peng
    Wu, Bailu
    Lv, Peijie
    Li, Zhen
    ACADEMIC RADIOLOGY, 2023, 30 : S40 - S52
  • [33] D-dimer for assessment of treatment response, and survival to drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma
    Duan, Youjia
    Hou, Xiaopu
    Guo, Jiang
    Li, Honglu
    Cai, Liang
    Cheng, Long
    Zhao, Wenpeng
    Shao, Xihong
    Du, Hongliu
    Diao, Zhenying
    Li, Changqing
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (04)
  • [34] Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)
    Liu, Yi-Sheng
    Chang, Pi-Yi
    Liang, Po-Chin
    Ou, Ming-Ching
    Hwang, Jen-, I
    Chen, Chien-Hung
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 811 - 821
  • [35] Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings
    Park, Hyun Jeong
    Kim, Jung Hoon
    Choi, Seo-youn
    Lee, Eun Sun
    Park, Sang Joon
    Byun, Jae Young
    Choi, Byung Ihn
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (04) : W211 - W220
  • [36] Comparison of liver injury and inflammatory response following conventional and drug-eluting bead transcatheter chemoembolization in hepatocellular carcinoma
    Ran You
    Bin Leng
    Chendong Wang
    Zeyu Yu
    Lingfeng Diao
    Ya Lu
    Qingyu Xu
    Guowen Yin
    Discover Oncology, 16 (1)
  • [37] Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis
    Han, Shilong
    Zhang, Xiaoping
    Zou, Liling
    Lu, Chenhui
    Zhang, Jun
    Li, Jue
    Li, Maoquan
    PLOS ONE, 2014, 9 (08):
  • [38] THE DIFFERENCE OF DOXORUBICIN AND CISPLATIN IN THE TRANSARTERIAL CHEMOEMBOLIZATION USING DRUG-ELUTING BEADS AGAINST INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA
    Asai, Akira
    Yasuoka, Hidetaka
    Ohama, Hideko
    Tsuchimoto, Yusuke
    Fukunishi, Shinya
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2019, 156 (06) : S1313 - S1314
  • [39] Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma
    Xi, Zihan
    Ye, Yuanxin
    Yang, Yongbo
    He, Yiwei
    Song, Ziyang
    Ma, Qian
    Zeng, Hui
    Shao, Guoliang
    ABDOMINAL RADIOLOGY, 2024, 49 (07) : 2387 - 2400
  • [40] Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
    Kazue Shiozawa
    Manabu Watanabe
    Takashi Ikehara
    Shuhei Yamamoto
    Takashi Matsui
    Yoshinori Saigusa
    Yoshinori Igarashi
    Iruru Maetani
    World Journal of Hepatology, 2018, 10 (01) : 95 - 104